CIK 0001061983
- Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 943291317
- Phone
- +1 650-624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- 4 Shares withheld for taxes President & CEO gave up 5,930 shares (to pay taxes)
- 4 Planned sale Director sold 8,750 shares at $63.90 ($559,125)
- 4 Planned sale EVP Research & Development sold 2,200 shares at $63.89 ($140,558)
- 4 Planned sale Director sold 28,064 shares at $66.72 ($1,872,430)
- 4 Planned sale Director sold 2,150 shares at $66.80 ($143,620)
- 4 Planned sale Director sold 5,000 shares at $64.73 ($323,650)
- 4 Planned sale EVP Research & Development sold 2,200 shares at $66.45 ($146,190)
- 4 Grant or award Chief Legal & Admin Officer acquired 87,297 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 5,175 shares at $65.08 ($336,789)
- 4 Gift President & CEO gave 2,000 shares (gift)
- 4 Planned sale EVP Research & Development sold 2,295 shares at $59.55 ($136,667)
- 4 Planned sale President & CEO sold 5,000 shares at $62.86 ($314,300)
- 4 Planned sale Director sold 4,375 shares at $58.68 ($256,725)
- 4 Planned sale EVP Research & Development sold 2,105 shares at $58.22 ($122,553)
- 4 Grant or award Director acquired 99 shares (grant or award)
- 4 Planned sale President & CEO sold 5,000 shares at $60.03 ($300,150)
- 4 Grant or award Director acquired 199 shares (grant or award)
- 4 Grant or award Director acquired 338 shares (grant or award)
- 4 Grant or award Director acquired 199 shares (grant or award)
Page 7 of 70 · 1,399 filings